TY  - BOOK
AU  - Nelson,Regina
TI  - Liver disease: diagnosis, treatment and management 
T2  - Hepatology research and clinical developments
SN  - 9781634857192
PY  - 2016///]
CY  - New York
PB  - Nova Biomedical
KW  - Liver
KW  - Diseases
KW  - Diagnosis
KW  - Treatment
N1  - Includes bibliographical references and index; Preface; Chapter 1; Hepatic Hydatidosis; Abstract; I. History of the Disease; II. Description of the Parasite Echinococcus Granulosus; III. Epidemiology of Hydatid Disease; IV. Life Cycle of the Parasite; V. Description of Hydatid Cyst; VI. Clinical Presentation of Hepatic Hydatidosis: Asymptomatic and Symptomatic; VII. Clinical Signs of Hepatic Hydatid Cyst; IX. Sequalae of Hepatic Hydatid Cyst; IX. Differential Diagnosis; X. Investigation of Hepatic Hydatid Disease; Routine and Diagnostic Investigations; Serological Investigation of the Hepatic Hydatidosis; XI. Treatment: Different ModalitiesSteps of the Operation; References; Chapter 2; Natural History of Chronic Hepatitis C Infection: Epidemiology, Outcomes, and Therapeutic Options; Abstract; Epidemiology; Virology/Molecular Biology; Natural History; Hepatitis C Screening; Diagnosis; History and Physical Examination; Laboratory Tests; Imaging; Testing for Fibrosis and Cirrhosis; Treatment; Indications and Considerations; Interferon and Ribavirin; Direct Acting Antiviral; Management; References; Chapter 3; Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease (NAFLD) and Psoriasis; Abstract; 1. Introduction2. Metabolic Syndrome; 2.1. Introduction and Definition of Metabolic Syndrome; 2.2. Epidemiology of Metabolic Syndrome; 2.3. Pathophysiology of Metabolic Syndrome; 3. Non-Alcoholic Fatty Liver Disease (NAFLD); 3.1. Introduction and Definition of NAFLD; 3.2. Epidemiology of NAFLD; 3.3. Pathophysiology of NAFLD; 4. Metabolic Syndrome and NAFLD -- The Link; 5. Psoriasis; 5.1. Introduction of Psoriasis; 5.2. Epidemiology of Psoriasis; 5.3. Pathophysiology of Psoriasis; 6. Metabolic Syndrome, NAFLD and Psoriasis -- The Link; 7. Treatment of Metabolic Syndrome, NAFLD and Skin Inflammation Co-Morbidity8. Animal Models of NAFLD and Psoriasis; Conclusion; References; Chapter 4; Pathophysiology and Treatment of Liver Cirrhosis; Abstract; Introduction; Pathophysiology of Cirrhosis; Cause of Cirrhosis; Symptom and Laboratory Findings of Cirrhosis; Diagnostic Methods for Liver Cirrhosis; Classification of Liver Function for Patients with Liver Cirrhosis; Prognosis of the Cirrhosis; Hypoalbuminemia in Cirrhosis; Ascites in Cirrhosis; Treatment of Cirrhosis; Administration of Albumin; Branched-Chain Amino Acid (Levact �); Albumin SynthesisDiuretics; References; Chapter 5; Surgical Strategies to Push up Resection Limits in Liver Disease and Liver Failure After Surgery; Abstract; Introduction; References; Section 1. Post-Hepatectomy Liver Failure (PHLF); From Transplantation Experience to Oncological Surgery Environment; Epidemiology; Risk Factors; References; Section 2. Classical Approach: The Concept of Size; TLV and FLRV: How to Calculate?; Manual, Semi-Automated and Automated Methods of CTV; References; Rationale and Historical Perspectives of Strategies to Push Up Liver Resection's Limits
UR  - https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1419207
ER  -